Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Antivir Ther
1 Cell
4 Clin Infect Dis
8 HIV Med
4 J Acquir Immune Defic Syndr
7 J Infect Dis
1 J Med Virol
2 J Virol
1 MMWR Morb Mortal Wkly Rep
1 Nature
15 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. HOLDEN CJ, Lampe FC, Burns FM, Chaloner C, et al
    Association of age at ART initiation with CD4:CD8 ratio recovery among virally suppressed people living with HIV, 2001-2019.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003801.
    PubMed         Abstract available

  2. JOHNSON LF, Myer L, Jamieson L, Meyer-Rath G, et al
    The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants: a modelling study.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003803.
    PubMed         Abstract available

  3. MA H, Liang W, Han A, Zhang Q, et al
    Ambient particulate matter and renal function decline in HIV/AIDS patients: exploring the mediating role of TyG index.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003802.
    PubMed         Abstract available

  4. TINCATI C, Bono V, Cannizzo ES, Tosi D, et al
    Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003799.
    PubMed         Abstract available

  5. CHERKOS AS, Cranmer LM, Njuguna I, LaCourse SM, et al
    Effect of TB-HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003797.
    PubMed         Abstract available

  6. JUSTMAN J, Wright C, El-Sadr WM
    Ending the HIV Epidemic in the US: lessons from Eswatini.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003726.

    AIDS Res Hum Retroviruses

  7. LI T, Qian K, Han J, Liu Y, et al
    Higher expression of HERV-K was observed in peripherial B Lymphocytes of Leukemia and Lymphoma Patients.
    AIDS Res Hum Retroviruses. 2023 Nov 27. doi: 10.1089/AID.2023.0037.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  8. HAN K, Gevorkyan H, Sadik Shaik J, Crauwels H, et al
    Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants.
    Antimicrob Agents Chemother. 2023 Dec 1:e0078123. doi: 10.1128/aac.00781.
    PubMed         Abstract available

    Antivir Ther

  9. BERKO J, Mazonson P, Short D, Karris M, et al
    Waitlist-controlled trial of an online intervention to address mental health among older people living with HIV.
    Antivir Ther. 2023;28:13596535231216311.
    PubMed         Abstract available


  10. DEZFULIAN MH, Kula T, Pranzatelli T, Kamitaki N, et al
    TScan-II: A genome-scale platform for the de novo identification of CD4(+) T cell epitopes.
    Cell. 2023 Nov 16:S0092-8674(23)01175-3. doi: 10.1016/j.cell.2023.
    PubMed         Abstract available

    Clin Infect Dis

  11. JAIN V
    Infection Control and Prevention During the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Nov 30:ciad611. doi: 10.1093.

  12. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice.
    Clin Infect Dis. 2023;77:1489-1491.

  13. THAKARAR K, Appa A, Abdul Mutakabbir JC, Goff A, et al
    Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections.
    Clin Infect Dis. 2023 Nov 29:ciad664. doi: 10.1093.

  14. THAKARAR K, Appa A, Abdul Mutakabbir JC, Goff A, et al
    Executive Summary: State-of-the-Art Review: Frame Shift-Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections.
    Clin Infect Dis. 2023 Nov 29:ciad665. doi: 10.1093.

    HIV Med

  15. LIEGEON G, Duffy A, Brooks C, Honour H, et al
    HIV pre-exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID).
    HIV Med. 2023 Dec 1. doi: 10.1111/hiv.13580.
    PubMed         Abstract available

  16. SAN FRANCISCO RAMOS A, Isitt C, Athaide S, Ladhani SN, et al
    Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
    HIV Med. 2023 Nov 28. doi: 10.1111/hiv.13586.
    PubMed         Abstract available

  17. POLICEK N, Mendao L
    Tackling ageism in the healthcare system: A community perspective.
    HIV Med. 2023;24:1172-1175.

  18. Abstracts of the 19th European AIDS Conference (#EACS2023), October 18-21, 2023, Warsaw, Poland.
    HIV Med. 2023;24 Suppl 5:3-788.

  19. LECLERC E, Jacomet C, Siproudhis L, Abramowitz L, et al
    Impact of screening programme to prevent anal cancer in high-risk patients with HIV.
    HIV Med. 2023 Nov 30. doi: 10.1111/hiv.13594.
    PubMed         Abstract available

  20. KEANE A, Lyons F, Aebi-Popp K, Feiterna-Sperling C, et al
    Guidelines and practice of breastfeeding in women living with HIV-Results from the European INSURE survey.
    HIV Med. 2023 Nov 29. doi: 10.1111/hiv.13583.
    PubMed         Abstract available

  21. OPREA C, Quirke S, Ianache I, Bursa D, et al
    HIV disease metrics and COVID-19 infection severity and outcomes in people living with HIV in central and eastern Europe.
    HIV Med. 2023 Nov 28. doi: 10.1111/hiv.13578.
    PubMed         Abstract available

  22. HILL L, Thompson C, Balcombe S, Jain S, et al
    Effects of a hospital discharge clinic among people with HIV: Lack of early follow-up is associated with 30-day hospital readmission and decreased retention in care.
    HIV Med. 2023 Nov 27. doi: 10.1111/hiv.13577.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  23. ROSEN JG, Knox JR, Rucinski KB, Mcingana M, et al
    Polysubstance Use Profiles and HIV Viremia in a South African Cohort of Female Sex Workers: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2023 Nov 30. doi: 10.1097/QAI.0000000000003356.
    PubMed         Abstract available

  24. FEELEMYER J, Bershteyn A, Scheidell JD, Brewer R, et al
    Impact of decarceration plus alcohol, substance use, and mental health screening on life expectancies of Black sexual minority men and Black transgender women (BSMM/BTW) living with HIV in the United States: A Simulation Study based on HPTN 061.
    J Acquir Immune Defic Syndr. 2023 Nov 28. doi: 10.1097/QAI.0000000000003354.
    PubMed         Abstract available

  25. BROOKS HL, Graves E, De Schacht C, Emilio A, et al
    "If it weren't for this, we'd be sick" - Perspectives from participants of a couple-based HIV treatment and support program during prenatal and postpartum periods in Zambezia Province, Mozambique.
    J Acquir Immune Defic Syndr. 2023 Nov 27. doi: 10.1097/QAI.0000000000003351.

  26. BEARDEN DR, Mwanza-Kabaghe S, Bositis CM, Dallah I, et al
    Early Initiation of Antiretroviral Therapy is Protective Against Seizures in Children with HIV in Zambia: A Prospective Case-Control Study.
    J Acquir Immune Defic Syndr. 2023 Nov 28. doi: 10.1097/QAI.0000000000003357.
    PubMed         Abstract available

    J Infect Dis

  27. BENLARBI M, Richard J, Bourassa C, Tolbert WD, et al
    Plasmatic HIV-1 soluble gp120 is associated with correlates of immune dysfunction and inflammation in ART-treated individuals with undetectable viremia.
    J Infect Dis. 2023 Nov 30:jiad503. doi: 10.1093.
    PubMed         Abstract available

  28. SCHALKWIJK HH, Georgala A, Gillemot S, Temblador A, et al
    A Herpes Simplex virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in an Immunocompromised Patient - Confirmed by Gene Editing.
    J Infect Dis. 2023 May 24:jiad184. doi: 10.1093.
    PubMed         Abstract available

  29. ALDRED B, Scott JY, Aldredge A, Gromer DJ, et al
    Associations between HIV and Severe Mpox in an Atlanta Cohort.
    J Infect Dis. 2023 Nov 24:jiad505. doi: 10.1093.
    PubMed         Abstract available

  30. DAMHORST GL, Fujita AW, Fitts E, Szabo B, et al
    Multisite mpox infection and viral dynamics among persons with HIV in metro-Atlanta.
    J Infect Dis. 2023 Nov 29:jiad530. doi: 10.1093.
    PubMed         Abstract available

  31. WELD ED, McGowan I, Anton P, Fuchs EJ, et al
    Tenofovir Douche as HIV Pre-Exposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, & Pharmacodynamics (DREAM 01).
    J Infect Dis. 2023 Nov 29:jiad535. doi: 10.1093.
    PubMed         Abstract available

  32. O'SHEA J, Zucker J, Stampfer S, Cash-Goldwasser S, et al
    Prolonged mpox disease in people with advanced HIV: characterization of mpox skin lesions.
    J Infect Dis. 2023 Nov 29:jiad532. doi: 10.1093.
    PubMed         Abstract available

  33. TUTTLE DJ, Castanha PMS, Nasser A, Wilkins MS, et al
    SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1.
    J Infect Dis. 2023 Nov 30:jiad544. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  34. LIM CK, Romeo O, Tran BM, Flanagan DJ, et al
    Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids.
    J Med Virol. 2023;95:e29232.
    PubMed         Abstract available

    J Virol

  35. MIN AK, Javidfar B, Missall R, Doanman D, et al
    HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model.
    J Virol. 2023 Nov 30:e0159523. doi: 10.1128/jvi.01595.
    PubMed         Abstract available

  36. LEE S-C, Naik NG, Tombacz D, Gulyas G, et al
    Hypoxia and HIF-1alpha promote lytic de novo KSHV infection.
    J Virol. 2023;97:e0097223.
    PubMed         Abstract available


    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.25077.

  38. ROSE MR, Chida NM, Jones JL
    Fourth-Generation HIV Testing.
    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.18137.

    MMWR Morb Mortal Wkly Rep

  39. AGATHIS NT, Faturiyele I, Agaba P, Fisher KA, et al
    Mortality Among Children Aged <5 Years Living with HIV Who Are Receiving Antiretroviral Treatment - U.S. President's Emergency Plan for AIDS Relief, 28 Supported Countries and Regions, October 2020-September 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1293-1299.
    PubMed         Abstract available


  40. NKENGASONG J, Reid M, Katz IT
    This is how the world finally ends the HIV/AIDS pandemic.
    Nature. 2023;623:907-909.

    PLoS One

  41. KIMANGA DO, Makory VNB, Hassan AS, Ngari F, et al
    Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis.
    PLoS One. 2023;18:e0291479.
    PubMed         Abstract available

  42. DE ANDA JA, Irvine MA, Zhang W, Salway T, et al
    Cost-effectiveness of internet-based HIV screening among gay, bisexual and other men who have sex with men (GBMSM) in Metro Vancouver, Canada.
    PLoS One. 2023;18:e0294628.
    PubMed         Abstract available

  43. DAVY-MENDEZ T, Sarovar V, Levine-Hall T, Lea AN, et al
    Racial, ethnic, and age disparities in the association of mental health symptoms and polysubstance use among persons in HIV care.
    PLoS One. 2023;18:e0294483.
    PubMed         Abstract available

  44. KAIZA R, Joho AA
    The effect of low-fidelity simulation training on breastfeeding knowledge, practice, and self-efficacy among young lactating mothers in Tanzania: A quasi-experimental study.
    PLoS One. 2023;18:e0285392.
    PubMed         Abstract available

  45. JOSEPH G, Milusheva S, Sturrock H, Mapako T, et al
    Estimating spatially disaggregated probability of severe COVID-19 and the impact of handwashing interventions: The case of Zimbabwe.
    PLoS One. 2023;18:e0292644.
    PubMed         Abstract available

  46. TACHIWENYIKA E, Dhodho M, Muchedzi A, Sibanda TP, et al
    Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
    PLoS One. 2023;18:e0294115.
    PubMed         Abstract available

  47. BUH A, Deonandan R, Gomes J, Krentel A, et al
    Barriers and facilitators for interventions to improve ART adherence in Sub-Saharan African countries: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295046.
    PubMed         Abstract available

  48. TILAHUN WM, Tesfie TK
    Spatial variation of premarital HIV testing and its associated factors among married women in Ethiopia: Multilevel and spatial analysis using 2016 demographic and health survey data.
    PLoS One. 2023;18:e0293227.
    PubMed         Abstract available

  49. JADKARIM L, Wickersham J, Gautam K, Azwa I, et al
    Correlates of never testing for HIV among men who have sex with men in Malaysia: A cross-sectional study.
    PLoS One. 2023;18:e0294937.
    PubMed         Abstract available

  50. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    PubMed         Abstract available

  51. MAYITO J, Meya DB, Miriam A, Dhikusooka F, et al
    Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
    PLoS One. 2023;18:e0291834.
    PubMed         Abstract available

  52. TOLLEFSON D, Dasgupta S, Setswe G, Reeves S, et al
    Impact of youth lay health workers on HIV service delivery in South Africa: A pragmatic cluster randomized trial of the Youth Health Africa program.
    PLoS One. 2023;18:e0294719.
    PubMed         Abstract available

  53. ALBERT H, Rupani S, Masini E, Ogoro J, et al
    Optimizing diagnostic networks to increase patient access to TB diagnostic services: Development of the diagnostic network optimization (DNO) approach and learnings from its application in Kenya, India and the Philippines.
    PLoS One. 2023;18:e0279677.
    PubMed         Abstract available

  54. ABERA NM, Alemu TG, Agegnehu CD
    Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia Region, Ethiopia: A retrospective follow up study.
    PLoS One. 2023;18:e0289095.
    PubMed         Abstract available

  55. SABRI B, Budhathoki C, McFall AM, Mehta SH, et al
    Cumulative violence exposures among men who have sex with men living with HIV in India: Psychosocial correlates of HIV care continuum outcomes.
    PLoS One. 2023;18:e0295225.
    PubMed         Abstract available

    PLoS Pathog

  56. DWIVEDI AK, Gornalusse GG, Siegel DA, Barbehenn A, et al
    A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.
    PLoS Pathog. 2023;19:e1011114.
    PubMed         Abstract available

  57. DOCKEN SS, McCormick K, Pampena MB, Samer S, et al
    Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency.
    PLoS Pathog. 2023;19:e1011755.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  58. AIT SAID M, Bejjani F, Abdouni A, Segeral E, et al
    Premature transcription termination complex proteins PCF11 and WDR82 silence HIV-1 expression in latently infected cells.
    Proc Natl Acad Sci U S A. 2023;120:e2313356120.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.